Medicover AB (publ)
MCOV-B.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$39.83B
Close$
$142.61
45.9% downside
Current Fair Value
45.9% downsideOvervalued by 45.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $39.83 Billion |
|---|---|
| Enterprise Value | $41.23 Billion |
| Dividend Yield | $2.20 (0.83%) |
| Earnings per Share | $0.51 |
| Beta | 1.5 |
| Outstanding Shares | 151,656,945 |
Return
| Return on Equity | 15.86% |
|---|---|
| Return on Assets | 3.49% |
| Return on Invested Capital | 11.89% |
Valuation & Multiples
| P/E Ratio | 42.01 |
|---|---|
| PEG | 148.59 |
| Price to Sales | 16.47 |
| Price to Book Ratio | 87.83 |
| Enterprise Value to Revenue | 16.66 |
| Enterprise Value to EBIT | 235.47 |
| Enterprise Value to Net Income | 484 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 2.77 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 22, 2026
EPS Estimate
$1.82
Average shareholder expectationRevenue Estimate
$7.09 B
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$1.90
Average shareholder expectationRevenue Estimate
$7.24 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Medicover AB (publ)
49,000 employees
CEO: John Paul Stubbington Medicover AB (publ) delivers healthcare and diagnostic solutions across multiple countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. The company operates through...